Pursuing Precision Medicine at Intermountain Healthcare

Feb 26, 2019 · 26 min · Episode 88 · 62.5 MB

0:00-26:04

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

What happens when Intermountain Healthcare invests resources in an innovative precision medicine unit to provide life-extending, genetically targeted therapies to late-stage cancer patients? Harvard Business School professors Richard Hamermesh and Kathy Giusti discuss their case — entitled “Intermountain Healthcare: Pursuing Precision Medicine” — and its connections to their work with the Kraft Precision Medicine Accelerator.